Librarian Capital's Research Library
Subscribe
Sign in
Home
Notes
Archive
Leaderboard
About
Latest
Top
Discussions
L’Oréal: Shares Down 24% in 2024 on Short-Term China, Tax Fears
P/E is now ~28x, cheap for a business with such resilience and long-term growth.
Dec 31, 2024
•
Librarian Capital
Share this post
Librarian Capital's Research Library
L’Oréal: Shares Down 24% in 2024 on Short-Term China, Tax Fears
Copy link
Facebook
Email
Notes
More
Croda: Poised for Rebound After Signs of Improvement in 2024
Shares are near a 5-year low, earnings should trough in 2024, and P/E is ~26x relative to these.
Dec 28, 2024
•
Librarian Capital
3
Share this post
Librarian Capital's Research Library
Croda: Poised for Rebound After Signs of Improvement in 2024
Copy link
Facebook
Email
Notes
More
Librarian Capital's Monthly Ranked Top Buys (December 2024)
Our "Select 15" portfolio is currently up 41.7% since the start of 2023, and we have our first double-bagger.
Dec 25, 2024
•
Librarian Capital
1
Share this post
Librarian Capital's Research Library
Librarian Capital's Monthly Ranked Top Buys (December 2024)
Copy link
Facebook
Email
Notes
More
2
Zoetis: Down 10%+ in Past Year Despite Strong Year-to-Date Results
Animal health earnings algorithm is powering ahead, and concerns about Elanco rival launches may be overstated.
Dec 17, 2024
•
Librarian Capital
Share this post
Librarian Capital's Research Library
Zoetis: Down 10%+ in Past Year Despite Strong Year-to-Date Results
Copy link
Facebook
Email
Notes
More
British American Tobacco: Patient is “Stable” in Pre-Close Update
No real improvement since H1 results and challenges remain, but an 8% Dividend Yield gives some margin of safety.
Dec 15, 2024
•
Librarian Capital
2
Share this post
Librarian Capital's Research Library
British American Tobacco: Patient is “Stable” in Pre-Close Update
Copy link
Facebook
Email
Notes
More
Brown-Forman: Why the 11% Rebound After Q2 FY25 Results?
We remain bullish on U.S. Spirits, but the results were less rosy than the headlines and tariffs are a risk.
Dec 10, 2024
•
Librarian Capital
1
Share this post
Librarian Capital's Research Library
Brown-Forman: Why the 11% Rebound After Q2 FY25 Results?
Copy link
Facebook
Email
Notes
More
November 2024
Librarian Capital's Monthly Ranked Top Buys (November 2024)
Our "Select 15" portfolio is currently up 39.6% since the start of 2023. We exit one holding to bring back another.
Nov 26, 2024
•
Librarian Capital
7
Share this post
Librarian Capital's Research Library
Librarian Capital's Monthly Ranked Top Buys (November 2024)
Copy link
Facebook
Email
Notes
More
8
Imperial Brands: Was FY24 as Good as the Market Thinks?
We were too pessimistic about IMB’s cigarette business, but structural risks have not gone away.
Nov 20, 2024
•
Librarian Capital
1
Share this post
Librarian Capital's Research Library
Imperial Brands: Was FY24 as Good as the Market Thinks?
Copy link
Facebook
Email
Notes
More
1
Procter & Gamble: A Safe Harbour from Potential Storms Ahead
Growth has been weaker recently, but for temporary reasons, and P&G remains well-placed against macro headwinds.
Nov 18, 2024
•
Librarian Capital
2
Share this post
Librarian Capital's Research Library
Procter & Gamble: A Safe Harbour from Potential Storms Ahead
Copy link
Facebook
Email
Notes
More
Estée Lauder: Capitulation at Last after Q1 FY25 Results?
We may have reached the point of maximum pessimism, and there is “new” management with a free hand.
Nov 7, 2024
•
Librarian Capital
2
Share this post
Librarian Capital's Research Library
Estée Lauder: Capitulation at Last after Q1 FY25 Results?
Copy link
Facebook
Email
Notes
More
Microsoft: Q1 FY25 Results Show Value Still Compounding
Shares down 10%+ since July, even as double-digit growth continues in all key metrics.
Nov 4, 2024
•
Librarian Capital
1
Share this post
Librarian Capital's Research Library
Microsoft: Q1 FY25 Results Show Value Still Compounding
Copy link
Facebook
Email
Notes
More
Altria: Don’t be Fooled by Q3 Timing Effects
Shares bounced 7.8% today, on results arguably worse than last quarter’s; P/E now exceeds 10x.
Nov 1, 2024
•
Librarian Capital
2
Share this post
Librarian Capital's Research Library
Altria: Don’t be Fooled by Q3 Timing Effects
Copy link
Facebook
Email
Notes
More
Share
Copy link
Facebook
Email
Notes
More
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts